Besides type, grade, and age, other prognostic factors include tumor size and location, extent of tumor resection, performance status, cognitive impairment, status of molecular markers such as IDH mutation, 1p/19q codeletion, MGMT promoter methylation and treatment protocols, including temozolomide and radiotherapy2,78. The gene discussed is MGMT; the disease is Cognitive impairment.